Investigation of the roles of IL-18 (-607 C/A) and IL-18 (-137 G/C) gene variations in bladder cancer development: case-control study
dc.authorid | Çevik, Gökhan/0000-0001-5221-5132 | |
dc.authorid | Alkanli, Nevra/0000-0002-3745-8838 | |
dc.authorwosid | Alkanli, Nevra/D-4400-2019 | |
dc.authorwosid | Çevik, Gökhan/GZA-3993-2022 | |
dc.contributor.author | Alkanli, Nevra | |
dc.contributor.author | Ay, Arzu | |
dc.contributor.author | Cevik, Gokhan | |
dc.date.accessioned | 2024-06-12T10:54:47Z | |
dc.date.available | 2024-06-12T10:54:47Z | |
dc.date.issued | 2021 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Background The purpose of our study is to investigate the roles of IL-18 gene variations in bladder cancer development in Thrace population of Turkey. Methods This study was carried out with 103 bladder cancer patients and 81 healthy controls. Genotype distributions of IL-18 (-137 G/C) and IL-18 (-607 C/A) gene variations were determined using polymerase chain reaction (PCR) method. Results The CC homozygous genotype for IL-18 (-607 C/A) gene variation was significantly higher in patients with bladder cancer compared to healthy controls (OR 0.345, 95% Cl 0.186-0.639, p = 0.001). Besides this, allele frequencies of IL-18 (-137 G/C) and IL-18 (-607 C/A) gene variations in patient with bladder cancer and healthy control groups were significantly different from the Hardy-Weinberg distribution (p < 0.05). For IL-18 (-137 G/C) and IL-18 (-607 C/A) gene variations, significant difference was determined between the bladder cancer patient and healthy control groups in terms of GC-CA (OR 0.381, 95% Cl 0.203-0.714, p = 0.002), GC-CC (OR 2.147, 95% Cl 1.013-4.550, p = 0.043), GG-AA (OR 0.431, 95% Cl 0.365-0.509, p = 0.049), and GG-CC (OR 2.476, 95% Cl 1.177-5.208, p = 0.015) haplotypes. Conclusion In our study, CC genotype of IL-18 (-607 C/A) gene variation was determined as genetic risk factor for bladder cancer development. In bladder cancer patient and healthy control groups, G and C allele frequencies of IL-18 (-137 G/C) gene variation, and C and A allele frequencies of IL-18 (-607 C/A) gene variation were determined significantly different from the Hardy-Weinberg distribution. | en_US |
dc.identifier.doi | 10.1007/s00432-021-03808-y | |
dc.identifier.endpage | 3637 | en_US |
dc.identifier.issn | 0171-5216 | |
dc.identifier.issn | 1432-1335 | |
dc.identifier.issue | 12 | en_US |
dc.identifier.pmid | 34550451 | en_US |
dc.identifier.scopus | 2-s2.0-85115296654 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 3627 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s00432-021-03808-y | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/19179 | |
dc.identifier.volume | 147 | en_US |
dc.identifier.wos | WOS:000698368600001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Journal Of Cancer Research And Clinical Oncology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Bladder Cancer | en_US |
dc.subject | IL-18 Gene | en_US |
dc.subject | IL-18 (-607 C | en_US |
dc.subject | A) Gene Variation | en_US |
dc.subject | IL-18 (-137 G | en_US |
dc.subject | C) Gene Variation | en_US |
dc.subject | PCR | en_US |
dc.subject | Serum Interleukin-18 | en_US |
dc.subject | Polymorphisms | en_US |
dc.subject | Risk | en_US |
dc.subject | Association | en_US |
dc.subject | Promoter | en_US |
dc.subject | Susceptibility | en_US |
dc.subject | Inflammation | en_US |
dc.title | Investigation of the roles of IL-18 (-607 C/A) and IL-18 (-137 G/C) gene variations in bladder cancer development: case-control study | en_US |
dc.type | Article | en_US |